EcoDrugPlus

Integrin Beta-1

Ensembl ID : ENSORLG00000001977
Gene Symbol: LOC101154978
4 Cross references
228 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSORLG00000010657
Gene Symbol: ITGA4
4 Cross references
225 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSORLG00000004051
Gene Symbol: ITGB6
4 Cross references
205 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSORLG00000003989
Gene Symbol: ITGB8
4 Cross references
202 Possible Orthologues:

Integrin, Alpha 5 (Fibronectin Receptor, Alpha Polypeptide)

Ensembl ID : ENSORLG00000015664
Gene Symbol: ITGA5
4 Cross references
206 Possible Orthologues:

Integrin, Alpha V

Ensembl ID : ENSORLG00000014126
Gene Symbol: ITGAV
4 Cross references
237 Possible Orthologues:

Integrin, Beta 1a

Ensembl ID : ENSORLG00000004663
Gene Symbol: ITGB1A
4 Cross references
213 Possible Orthologues:

Integrin, Beta 5

Ensembl ID : ENSORLG00000020862
Gene Symbol: ITGB5
4 Cross references
205 Possible Orthologues:

Interleukin-1 Receptor-Associated Kinase 4

Ensembl ID : ENSORLG00000003134
Gene Symbol: IRAK4
4 Cross references
202 Possible Orthologues:

Inward Rectifier Potassium Channel 2

Ensembl ID : ENSORLG00000027881
Gene Symbol: LOC101171082
3 Cross references
202 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSORLG00000008218
Gene Symbol: IDH2
4 Cross references
207 Possible Orthologues:

Isocitrate Dehydrogenase [Nadp], Mitochondrial

Ensembl ID : ENSORLG00000012601
Gene Symbol: LOC101166704
3 Cross references
186 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).